News | ROHTO Pharmaceutical Co., Ltd.

STAT

Reporting from the frontiers of health and medicine

Kao | Resarch & Development News Release

Homepage - openRxiv

openRxiv is an independent non-profit, the new organizational home for bioRxiv and medRxiv, enabling researchers to instantly share groundbreaking findings with the global scientific community.

The FDA Sentinel Real World Evidence Data Enterprise ( RWE ‐ DE )

Purpose The US Food and Drug Administration's Sentinel Innovation Center aimed to establish a query-ready, quality-checked distributed data network containing electronic health records (EHRs) linked...

The FDA Sentinel Real World Evidence Data Enterprise ( RWE ‐ DE )

Purpose The US Food and Drug Administration's Sentinel Innovation Center aimed to establish a query-ready, quality-checked distributed data network containing electronic health records (EHRs) linked...

Ramez Naam on Twitter / X

There was a site years ago called CureTogether where patients could share information in a structured way on their disease, regimen, and progress, working towards a sort of bottoms-up clinical trial. 23andMe acquired them and it seems to be mostly dead.— Ramez Naam (@ramez) September 14, 2025

Kao | News Release

Visit Kao's newsroom for news releases and Kao Stories, which introduce our latest initiatives.

Mozilla’s response to proposed remedies in U.S. v. Google | The Mozilla Blog

Last week the Department of Justice and some state attorneys general filed revised proposed remedies in the U.S. v. Google LLC search case. If the proposed

News | Ryohin Keikaku Co., Ltd.

This is the page about News of Ryohin Keikaku Co., Ltd.

OpenAI Has New Focus (on the IPO)

The Wall Street Journal recently reported that leadership wants OpenAI, the company, to focus. Seems like a plain old business strategy story. Nope! First, in more prosaic terms, the all-hands and …

Luosheng Peng on Twitter / X

$SAVA @CassavaSciencesI'm long $SAVA & have been a known supporter of your effort to develop Simufilam as a potential breakthru AD treatment drug.I've stumbled across a couple of errors in your AAIC July 2021 poster presentation & hope can get clarifications from you.Cont'd— Luosheng Peng (@LuoshengPeng) August 27, 2021

Plan S

Plan S is an initiative for open-access science publishing launched in 2018[1][2] by "cOAlition S",[3] a consortium of national research agencies and funders from twelve European countries. The plan requires scientists and researchers who benefit from state-funded research organisations and institutions to publish their work in open repositories or in journals that are available to all by 2021.[4] The "S" stands for "shock".[5]